GLI3 in cancer: a context-dependent regulator with diagnostic, prognostic, and therapeutic potential - Top-Institutions - MDSpire

GLI3 in cancer: a context-dependent regulator with diagnostic, prognostic, and therapeutic potential

  • By

  • Yilin Wang

  • Jiayan Wu

  • Duocheng Zhong

  • Xiong Jun

  • July 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, Florida

    Key Differentiators

    • Oncology

  • #4

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio

    Key Differentiators

    • Oncology

  • #5

    University of New Mexico Comprehensive Cancer Center
    University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico

    Key Differentiators

    • Oncology

Original Source(s)

GLI3 in cancer: a context-dependent regulator with diagnostic, prognostic, and therapeutic potential

  • by Yilin Wang, Jiayan Wu, Duocheng Zhong, Xiong Jun

  • July 8, 2026

Related Content

Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets

Predictive value of Ki-67 expression in predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy in lung squamous cell carcinoma

Physical activity as a molecular modulator to enhance immunotherapy and drug sensitivity in the endometrial cancer–comorbidity continuum